Prof. Pei-Jer Chen

Internal Medicine, Gastroenterology, Molecular biology and virology, Cancer genome

Ph.D., University of Pennsylvania, Philadelphia, U.S.A.

• Academician, Academia Sinica (Taiwan, ROC.)
• Attending Physician, DEPT. of Gastroenterology and Hepatology, National Taiwan University Hospital (NTHU),
• Professor, College of Medicine, NTU.
• Outstanding Technological Talent, Executive Yuan, Taiwan, ROC.
• Main Principal investigator of BELX’s HBV phase II trial 

Prof. Po-Huang Lee

Hepatobiliary surgery, Liver Transplantation

Ph.D., Institute of Clinical Medicine National Taiwan University College of Medicine

• Director, DEPT. of Medicine and Surgery, NTUH
• Professor of Surgery, College of Medicine, NTU
• Member and Vice President, International Society for Digestive Surgery
• President, Asian Surgical Association

Dr. Shaw T Chen

International drug regulation, Clinical trial, Drug safety monitoring

Doctor of Medicine, University of Miami, U.S.A.

Ph.D., Johns Hopkins University, U.S.A

• Director of Botanical Drugs, U.S. FDA
• Deputy Director of Audit Department, U.S. FDA
• Biotechnology Advisory Committee, Executive Yuan, Taiwan ROC.
• Executive Vice President, Polaris Pharma

Chih-Hsien Liu

Clinical trial, Biostatistics,

Business plan

MS, Statistics,

The University of Iowa, U.S.A.

MSCS, Computer Science,

University of Minnesota, U.S.A

• Chairman, Fidelitas Int. Corporation
• Vice president, General manager Asia pacific, PAREXEL International
• Chairman, Apex Int. Clinical Research
• Instructor, Ins. of Clinical Medicine, NYCU

Dr. Lai-Ju Chen

Startup enterprise, 

Marketing

Thunderbird School of Global Management

Ph.D., Chemical Engineering. National Tsing Hua University

• Manager, ITRI
• President and CEO of, AUO
• Angel Business Committee of National Development Fund, Executive Yuan
• CEO, Sunnyhills
• Chairman, Kingyoup Optronics. Co., Ltd.

Dr. Yu-Li Chang

Botanical new drug development & management

Ph.D., University of Pennsylvania, Philadelphia, U.S.A.

• Program Director, Botanical new drug development program sponsored by DOIT of MOEA, ITRI
• Division Director, Herbal Medicinal Product Technology Division, ITRI
• Director, Bulk pharmaceuticals pilot plant, ITRI
• Co-founder, BELX Bio-pharmaceutical

Wei-Min Chang

Marketing, Pharmaceutical PIC/S GMP manufacturing

M.S.,ChE, Connecticut University, U.S.A.

• Vice President, Savior Lifetec Co.
• Vice President of New Drug Operations, WuXi AppTec
• General Manager, Keystone Pharmaceuticals
• Manager, Everlight Chemical Co.